SurgePays, Inc.
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Brenda Lulenar LawrenceHouse · D · MI |
SURGSurgePays, Inc. · Stock |
Purchase $1,001 - $15,000 |
Aug 21, 2019 | Jul 12, 2018 | Filing ↗ |
Whale Activity
- Increased1
- New1
- Held1
- Decreased1
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 567.4K | $205K | held |
| CITADEL ADVISORS LLC | 83.2K | $30K | new |
| RENAISSANCE TECHNOLOGIES LLC | 50.9K | $18K | increased |
| BlackRock, Inc. | 29.3K | $11K | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| May David AllenDirector | Purchase | +34.7K | $0.53 | $18K | Jun 5, 2026 | Form 4 ↗ |
| May David AllenDirector | Purchase | +121 | $0.53 | $64 | Jun 4, 2026 | Form 4 ↗ |
| May David AllenDirector | Purchase | +5,413 | $0.53 | $3K | Jun 3, 2026 | Form 4 ↗ |
| Cox Kevin BrianCEO & Chairman · Director · 10% owner | Grant / award | +500.0K | $0.00 | $0 | Jun 1, 2026 | Form 4 ↗ |
| Cox Kevin BrianCEO & Chairman · Director · 10% owner | Grant / award | +500.0K | $0.00 | $0 | Apr 1, 2026 | Form 4 ↗ |
| Cox Kevin BrianCEO & Chairman · Director · 10% owner | Gift | +270.7K | $0.00 | $0 | Mar 24, 2026 | Form 4 ↗ |
| Cox Kevin BrianCEO & Chairman · Director · 10% owner | Gift | −270.7K | $0.00 | $0 | Mar 24, 2026 | Form 4 ↗ |
| Cox Kevin BrianCEO & Chairman · Director · 10% owner | Grant / award | +800.0K | $1.25 | $1.0M | Mar 23, 2026 | Form 4 ↗ |
| Evers Anthony GeorgeChief Financial Officer | Grant / award | +200.0K | $0.00 | $0 | Dec 31, 2025 | Form 4 ↗ |
| May David AllenDirector | Purchase | +10.0K | $1.62 | $16K | Dec 10, 2025 | Form 4 ↗ |
| May David AllenDirector | Purchase | +28.4K | $1.60 | $45K | Dec 10, 2025 | Form 4 ↗ |
| May David AllenDirector | Sale | −63.0K | $2.81 | $177K | Jun 6, 2025 | Form 4 ↗ |
| KEYS DAVID NDirector | Grant / award | +50.0K | $0.00 | $0 | May 22, 2025 | Form 4 ↗ |
| Weisberg LaurieDirector | Grant / award | +50.0K | $0.00 | $0 | May 22, 2025 | Form 4 ↗ |
| Schurfeld Richard EarlDirector | Grant / award | +50.0K | $0.00 | $0 | May 22, 2025 | Form 4 ↗ |
| Cox Kevin BrianCEO and Chairman of Board · Director | Purchase | +15.1K | $2.75 | $41K | May 16, 2025 | Form 4 ↗ |
| Cox Kevin BrianCEO and Chairman of Board · Director | Sale | −35.2K | $1.82 | $64K | Dec 3, 2024 | Form 4 ↗ |
| Evers Anthony GeorgeChief Financial Officer | Sale | −36.7K | $1.86 | $68K | Dec 2, 2024 | Form 4 ↗ |
| Weisberg LaurieDirector | Purchase | +3,099 | $1.84 | $6K | Nov 25, 2024 | Form 4 ↗ |
| Weisberg LaurieDirector | Purchase | +1,500 | $1.84 | $3K | Nov 25, 2024 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 418.4K | $151K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 125.1K | $74K | 0.00% | May 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 148.9K | $54K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF iSHARES TRUST | 38.3K | $29K | 0.00% | Mar 31, 2026 |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 23.8K | $14K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 19.6K | $12K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 15.1K | $9K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio EQ ADVISORS TRUST | 2,896 | $2K | 0.00% | Mar 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list SURG's shares (CUSIP 86882L204), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming SurgePays, Inc. as the client.
Government Contracts
No federal contract awards found for SurgePays, Inc..
U.S. Patents
No USPTO patent applications found for SurgePays, Inc..
Annual Financials
No annual XBRL figures on record for SURG. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
- 1-for-50Reverse splitNov 2, 2021
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
- 8-K/A · Items 9.01Sep 30, 2026
EDGAR ↗ - 8-K · Items 3.01Delisting noticeSep 29, 2026
EDGAR ↗ - 8-K · Items 4.01Change in auditorSep 16, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.01, 8.01, 9.01Material agreement · Acquisition or disposition · Other eventsSep 10, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsSep 3, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsAug 5, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJul 29, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJul 1, 2026
EDGAR ↗ - 8-K · Items 5.07, 9.01Shareholder voteJun 22, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 3.02, 9.01Material agreement · Direct financial obligation · Unregistered sale of equityJun 22, 2026
EDGAR ↗

